Tyler L Dangerfield

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Molecular Dynamics Simulations

Respiratory Syndrome Coronavirus

Top Venues

Nature communications

ACS bio & med chem Au

This page only lists publications with an associated author ORCID identifier.

Publications

Evan A Schwartz, Jack P K Bravo, Mohd Ahsan, Luis A Macias, Caitlyn L McCafferty, Tyler L Dangerfield, Jada N Walker, Jennifer S Brodbelt, Giulia Palermo, Peter C Fineran, Robert D Fagerlund, David W Taylor
RNA targeting and cleavage by the type III-Dv CRISPR effector complex. Nature communications 15 (1) (2024)
Evan A Schwartz, Jack P K Bravo, Mohd Ahsan, Luis A Macias, Caitlyn L McCafferty, Tyler L Dangerfield, Jada N Walker, Jennifer S Brodbelt, Giulia Palermo, Peter C Fineran, Robert D Fagerlund, David W Taylor
RNA targeting and cleavage by the type III-Dv CRISPR effector complex. Nature communications 15 (1) (2024)
Evan A Schwartz, Jack P K Bravo, Mohd Ahsan, Luis A Macias, Caitlyn L McCafferty, Tyler L Dangerfield, Jada N Walker, Jennifer S Brodbelt, Giulia Palermo, Peter C Fineran, Robert D Fagerlund, David W Taylor
RNA targeting and cleavage by the type III-Dv CRISPR effector complex. Nature communications 15 (1) (2024)
Evan A Schwartz, Jack P K Bravo, Mohd Ahsan, Luis A Macias, Caitlyn L McCafferty, Tyler L Dangerfield, Jada N Walker, Jennifer S Brodbelt, Giulia Palermo, Peter C Fineran, Robert D Fagerlund, David W Taylor
RNA targeting and cleavage by the type III-Dv CRISPR effector complex. Nature communications 15 (1) (2024)
Evan A Schwartz, Jack P K Bravo, Mohd Ahsan, Luis A Macias, Caitlyn L McCafferty, Tyler L Dangerfield, Jada N Walker, Jennifer S Brodbelt, Giulia Palermo, Peter C Fineran, Robert D Fagerlund, David W Taylor
RNA targeting and cleavage by the type III-Dv CRISPR effector complex. Nature communications 15 (1) (2024)
Evan A Schwartz, Jack P K Bravo, Mohd Ahsan, Luis A Macias, Caitlyn L McCafferty, Tyler L Dangerfield, Jada N Walker, Jennifer S Brodbelt, Giulia Palermo, Peter C Fineran, Robert D Fagerlund, David W Taylor
RNA targeting and cleavage by the type III-Dv CRISPR effector complex. Nature communications 15 (1) (2024)
Tyler L Dangerfield, Kenneth A Johnson
Substrate Specificity and Kinetics of RNA Hydrolysis by SARS-CoV-2 NSP10/14 Exonuclease. ACS bio & med chem Au 2 (6) (2022)
Tyler L Dangerfield, Kenneth A Johnson
Substrate Specificity and Kinetics of RNA Hydrolysis by SARS-CoV-2 NSP10/14 Exonuclease. ACS bio & med chem Au 2 (6) (2022)